-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
Melanin Concentrating Hormone Receptor 1 Market Overview
Posté 2026-06-23 08:59:06
0
50
The Melanin Concentrating Hormone Receptor 1 Market is gaining significant traction in the pharmaceutical landscape, valued at USD 300 million in 2024 and projected to reach USD 500 million by 2035. MCHR1 is a G-protein coupled receptor that plays a critical role in regulating feeding behavior, energy homeostasis, and sleep-wake cycles. The market is primarily driven by rising obesity prevalence and increasing research into metabolic disorders.
Drug development focuses on MCHR1 antagonists for obesity management and MCHR1 agonists for potential applications in mood disorders. Small molecule drugs currently hold approximately 40% market share, followed by peptide-based drugs and biologics. Leading pharmaceutical companies including Novartis, Eli Lilly, and AstraZeneca are actively developing MCHR1-targeted therapies through strategic collaborations and acquisitions.
North America dominates the regional landscape with a 34.3% market share, supported by robust healthcare infrastructure and substantial R&D investments. The market is expected to grow at a CAGR of 5.9% through 2035, reflecting sustained interest in neuroendocrine therapeutic targets.
FAQ
Q1: What is the current size of the MCHR1 market? A: The market was valued at USD 300 million in 2024.
Q2: What is the projected CAGR for this market? A: The market is expected to grow at a CAGR of 5.9% from 2025 to 2035.
Q3: Which region leads the MCHR1 market? A: North America holds the largest market share at approximately 34.3%.
Rechercher
Catégories
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jeux
- Gardening
- Health
- Domicile
- Literature
- Music
- Networking
- Autre
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
Lire la suite
Patient Enrollment Services Market Forecast 2025-2035: How Targeted Recruitment Strategies Are Accelerating Clinical Trial Timelines and Improving Diversity
Patient enrollment services are a specialized segment of the clinical trial recruitment market,...
Anti-Venom Market - Research Innovation and Future Treatment Development
Market Overview
Research innovation is developing next-generation anti-venoms with improved...
VMAT2 Inhibitors Market Research on Tardive Dyskinesia and Huntington Disease Treatment
Product differentiation is a primary theme within the Vmat2 Inhibitors Market, as developers seek...
Breaking: Optical Chemical Sensors Market Poised for Significant Expansion by 2035
The Optical Chemical Sensors Market is on the cusp of substantial growth, reflecting a projected...
Competitive Landscape Analysis of the EPTFE Vascular Graft Market
The international Eptfe Vascular Graft Market is entering a highly productive era of commercial...
English